These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22817711)

  • 21. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies.
    Jiang Y; MacNeil LT
    Mol Neurodegener; 2023 Nov; 18(1):82. PubMed ID: 37950311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive neurodegeneration in C. elegans model of tauopathy.
    Miyasaka T; Ding Z; Gengyo-Ando K; Oue M; Yamaguchi H; Mitani S; Ihara Y
    Neurobiol Dis; 2005 Nov; 20(2):372-83. PubMed ID: 16242642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Threonine
    Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
    Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.
    Jadhav VS; Stair JG; Eck RJ; Smukowski SN; Currey HN; Toscano LG; Hincks JC; Latimer CS; Valdmanis PN; Kraemer BC; Liachko NF
    Neurobiol Dis; 2024 Apr; 193():106441. PubMed ID: 38378122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
    Clavaguera F; Grueninger F; Tolnay M
    Neuropharmacology; 2014 Jan; 76 Pt A():9-15. PubMed ID: 24050961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SUT-1 enables tau-induced neurotoxicity in C. elegans.
    Kraemer BC; Schellenberg GD
    Hum Mol Genet; 2007 Aug; 16(16):1959-71. PubMed ID: 17576746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
    Brandt R; Hundelt M; Shahani N
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered Proteostasis in Neurodegenerative Tauopathies.
    Papanikolopoulou K; Skoulakis EMC
    Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation.
    Nisha ; Sarkar S
    Neurochem Int; 2021 Jun; 146():105040. PubMed ID: 33865914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.
    Schaeffer V; Lavenir I; Ozcelik S; Tolnay M; Winkler DT; Goedert M
    Brain; 2012 Jul; 135(Pt 7):2169-77. PubMed ID: 22689910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Pathogenesis of the Tauopathies.
    Götz J; Halliday G; Nisbet RM
    Annu Rev Pathol; 2019 Jan; 14():239-261. PubMed ID: 30355155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.